A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...
News-Medical.Net on MSN
UC Davis team creates new class of serotonin-effecting drugs
UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - ...
UC Davis researchers have developed a new method that uses light to transform amino acids—the building blocks of ...
A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...
Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...
An investigational immunomodulator gel significantly improved malodor and measures related to pain and quality of life for ...
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that the first participant has been dosed in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback